Pharmaceuticals Companies in Sheffield: 106 Active Firms (2026)

Sheffield has 106 actively trading pharmaceutical firms in and around the city, a relatively compact local cohort with a spread across import, licence-holding, development, manufacturing and wholesale distribution models. Reported employment totals 43 people, which suggests much of the visible base sits in small specialist operators rather than large local plants. The city-area market also includes a limited set of higher-turnover businesses, so it is not only pre-commercial; some firms appear to have reached repeatable supply or manufacturing revenue.

Human-medicines operators in this market sit under the MHRA’s permissions regime. Manufacturing, assembly and import activity generally requires a manufacturer’s licence, evidence of good manufacturing practice and readiness for regular site inspection; wholesale supply to anyone other than the patient brings wholesale distribution licensing and good distribution practice obligations. Products also need marketing authorisation, with pharmacovigilance duties continuing after approval. Where medicines seek publicly funded healthcare access, cost-effectiveness review adds another gate beyond regulatory approval, which tends to favour operators that can maintain both technical evidence and commercial documentation.

The cohort appears likely to remain divided between specialist licence holders, importers and wholesalers at one end and a smaller group of development or manufacturing-led operators at the other. Regulatory pressure tends to raise the cost of moving from early commercial activity into repeatable production, so scale-up scarcity may persist. Buyers in healthcare and research channels are also likely to favour suppliers with documented quality systems and inspection history. Consolidation appears plausible where smaller operators hold permissions or niche channel access, but local growth is likely to be uneven rather than broad-based.